Conversely, an optimal cut-off value to determine the CDX2 expression status in whole CRC sections might be necessary if CDX2 expression determined by TMAs is utilized in daily medical practice as a prognostic or predictive biomarker for response to chemotherapy. Here, CDX2 is linked to colorectal carcinoma.